Skip to main content

Persistent Asset Partners Ltd

Source: SEC Form 13F · as of Mar 2026

Persistent Asset Partners Ltd holds 74 biotech & pharma companies tracked by BioSniper, totaling $48.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

74

Total value held

$48.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Viking Therapeutics, Inc. (VKTX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
VKTXViking Therapeutics, Inc.133,066$4.3M
COGTCogent Biosciences, Inc.92,516$3.6M
JAZZJazz Pharmaceuticals plc15,905$3.0M
ABVXAbivax SA22,838$2.5M
RVMDREVOLUTION MEDICINES, INC.26,043$2.5M
TERNTerns Pharmaceuticals, Inc.45,953$2.4M
BMRNBIOMARIN PHARMACEUTICAL INC37,472$2.1M
KODKodiak Sciences Inc.51,336$2.0M
INCYIncyte Corp.19,782$1.9M
BBIOBridgeBio Pharma, Inc.23,810$1.8M
TGTXTG THERAPEUTICS, INC.53,080$1.8M
IMCRImmunocore Holdings plc48,962$1.5M
RCUSArcus Biosciences, Inc.60,203$1.3M
CRBPCorbus Pharmaceuticals Holdings, Inc.111,226$1.0M
TENXTENAX THERAPEUTICS, INC.58,182$930K
ZYMEZymeworks Inc.35,935$900K
GPCRStructure Therapeutics Inc.18,263$880K
IVAInventiva S.A.128,099$711K
HRMYHarmony Biosciences Holdings, Inc.23,548$660K
DNTHDianthus Therapeutics, Inc. /DE/7,442$625K
CAPRCAPRICOR THERAPEUTICS, INC.19,933$606K
MANEVeradermics Incorporated9,191$580K
BCYCBICYCLE THERAPEUTICS PLC120,437$559K
CLYMClimb Bio, Inc.72,325$495K
TNGXTango Therapeutics, Inc.23,116$484K
SNYSanofi9,946$479K
NKTRNEKTAR THERAPEUTICS5,820$419K
VYGRVoyager Therapeutics, Inc.107,094$413K
CMPXCompass Therapeutics, Inc.72,193$382K
RLMDRELMADA THERAPEUTICS, INC.50,773$353K
PCVXVaxcyte, Inc.5,319$309K
REGNREGENERON PHARMACEUTICALS, INC.400$309K
DFTXDefinium Therapeutics Inc.15,861$300K
SABSSAB BIOTHERAPEUTICS, INC.69,732$267K
BIOABioAge Labs, Inc.15,167$265K
MAZEMaze Therapeutics, Inc.8,768$262K
ELVNEnliven Therapeutics, Inc.6,606$259K
AYTUAYTU BIOPHARMA, INC92,897$254K
INOINOVIO PHARMACEUTICALS, INC.142,164$247K
SYRESpyre Therapeutics, Inc.4,803$242K
PHVSPharvaris N.V.7,904$223K
KTTAPasithea Therapeutics Corp.290,555$216K
SRZNSurrozen Inc.7,143$208K
XERSXeris Biopharma Holdings, Inc.35,661$207K
SLDBSolid Biosciences Inc.27,990$202K
LRMRLarimar Therapeutics, Inc.42,124$190K
ANNXAnnexon, Inc.33,625$186K
ARGXARGENX SE253$185K
STROSUTRO BIOPHARMA, INC.7,411$185K
KALVKalVista Pharmaceuticals, Inc.9,001$181K
FBRXForte Biosciences, Inc.6,744$175K
ARWRARROWHEAD PHARMACEUTICALS, INC.2,661$167K
RLAYRelay Therapeutics, Inc.16,358$163K
DMRADamora Therapeutics, Inc.5,338$138K
ADAGAdagene Inc.35,126$138K
ANTXAN2 Therapeutics, Inc.38,155$130K
QUREuniQure N.V.7,887$129K
PTHSPelthos Therapeutics Inc.6,007$126K
AVTXAvalo Therapeutics, Inc.7,918$118K
LPCNLipocine Inc.13,442$107K
GHRSGH Research PLC6,794$96K
ADPTAdaptive Biotechnologies Corp6,689$93K
OCGNOcugen, Inc.50,559$92K
IRDOpus Genetics, Inc.17,919$82K
PRQRProQR Therapeutics N.V.46,067$75K
IVVDInvivyd, Inc.55,990$73K
PGENPRECIGEN, INC.13,978$54K
UPBUpstream Bio, Inc.5,495$49K
CMPSCOMPASS Pathways plc8,060$45K
TLPHTALPHERA, INC.38,968$29K
RCKTRocket Pharmaceuticals Inc.7,731$28K
VTGNVistagen Therapeutics, Inc.26,612$15K
CUECue Biopharma, Inc.33,369$8K
RNAAtrium Therapeutics Inc.283$4K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.